Shorted
Medibio logo
MEB

Medibio

Short interest
0.00%
−0.10 pp 30d
as of 23 July 2020
Reported shorts
66.8K
Shares on issue
1.348B

Medibio (MEB) company profile

Profile, insiders and operations

Director trades

20 trades recorded

DateDirectorTypeSharesPriceValue
2025-12-19David Trimboli
other
6,250,000$0.008$50,000
2025-12-19Christopher Ntoumenopoulos
other
86,250,000$0.006$547,500
2025-12-19David Trimboli
buy
---
2025-12-19Chris Ntoumenopoulos
buy
---
2025-12-02Christopher Ntoumenopoulos
other
9,739,726$0.011$102,910
2025-12-02David Trimboli
other
10,287,671$0.011$114,910
2025-12-02Tony Keating
other
9,739,726$0.011$102,910
2025-12-02John Mathias
other
2,500,000$0.006$15,325
2025-12-02John Mathias
buy
---
2025-12-02David Trimboli
buy
---
2025-12-02Tony Keating
buy
---
2025-12-02Chris Ntoumenopoulos
buy
---
2025-10-02John Mathias
buy
---
2025-10-01John Mathias
other
50,000--
2024-12-05Chris Ntoumenopoulos
buy
---
2024-12-05David Trimboli
buy
---
2024-12-05Tony Keating
buy
---
2024-12-04David Trimboli
other
5,090,909$0.013$64,800
2024-12-04Tony Keating
other
4,227,272$0.011$45,800
2024-12-04Christopher Ntoumenopoulos
other
4,909,090$0.012$60,800

MEB intelligence dossier

Public-source evidence for this company, with industry drill-up links.

  • Tax paid and taxable income records
  • Government contracts and public money
  • Emissions and trade exposure
  • Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required